** Synthetic biological products maker Twist Bioscience's TWST.O shares rise 13.8% to $41.99 premarket
** Co's fiscal Q4 rev of $84.7 mln beats analysts' est of $82.2 mln - LSEG
** Co reports fiscal Q4 loss of 59 cents/share, smaller than analysts' est of a loss of 71 cents/share - LSEG
** Co forecasts rev of $367 mln to $377 mln for fiscal year ending Sept 2025 vs est of $371.4 mln - LSEG
** TWST also forecasts Q1 FY25 rev of ~87 mln
** Nine of 12 brokerages rate the stock "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $54 - LSEG
** As of last close, stock has risen 0.1% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。